Translate
Macrogenics Inc
About
Macrogenics Inc (NASDAQ:MGNX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
Mar 9 2026
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Feb 23 2026
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Nov 25 2025
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
Nov 12 2025
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
Financials
Revenue
$149.5 M
Market Cap
$195.12 M
EPS
-1.18